2 of the best ASX 200 blue-chip shares to buy in May

These blue chips are best buys according to a couple of leading brokers.

| More on:
A group of businesspeople clapping.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There are plenty of blue-chip shares on the ASX 200 index. But which ones could be buys in May?

Let's take a look at two shares that are rated as best buys by a couple of leading brokers right now. They are as follows:

Coles Group Ltd (ASX: COL)

Analysts at Morgans think that this supermarket giant would be a great ASX 200 blue-chip share to buy this month. So much so, the broker has added it to its best ideas list in May.

It believes that recent share price weakness has created a buying opportunity for investors. The broker said:

In our view, the ongoing scrutiny on the supermarkets has affected short term sentiment in the sector, which we believe creates a good buying opportunity in COL. While Liquor sales remain soft, we expect the core Supermarkets division (~92% of earnings) to continue to be supported by further improvement in product availability, reduction in total loss, greater in-home consumption due to cost-of-living pressures, and population growth.

Morgans currently has an add rating and $18.95 price target on the company's shares. This implies a potential upside of 15% for investors over the next 12 months. The broker also expects a ~4% fully franked dividend yield from its shares.

ResMed Inc. (ASX: RMD)

The team at Bell Potter has named this sleep disorder treatment company as an ASX 200 blue-chip share to buy. Its analysts have ResMed on their Australian Equities Panel. These are the broker's favoured Australian equities that offer attractive risk-adjusted returns over the long term.

Bell Potter likes the company due to its significant opportunity as a leader in obstructive sleep apnoea (OSA) and other sleep disorders. It said:

The market for OSA and chronic obstructive pulmonary disease (COPD) remains under penetrated, and we expect industry volume growth to continue in the 6-8% range for the foreseeable future. In this regard, the competitive dynamics are very much in favour of RMD due to the Philips recall and improving semiconductor availability. Looking ahead, ResMed continues to expect device sales to be sequentially higher throughout CY2023. Furthermore, ResMed is well-positioned to build on its dominant share even after Philips returns to the global market, with the launch of its latest continuous positive airway pressure (CPAP) device, the Air Sense 11.

The broker has a buy rating and a $36.00 price target on its shares. This suggests a potential upside of 9% is possible over the next 12 months.

Motley Fool contributor James Mickleboro has positions in ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed. The Motley Fool Australia has positions in and has recommended Coles Group and ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Blue Chip Shares

Analysts say these strong ASX 200 blue chip shares are top buys today

These blue chips tick a lot of boxes for analysts. Here's why they are bullish.

Read more »

a man with a wide, eager smile on his face holds up three fingers.
Blue Chip Shares

3 of the best ASX 200 blue chip shares to buy now

Analysts think these blue chip stars could be quality options for investors this month.

Read more »

A group of businesspeople clapping.
Blue Chip Shares

Why analysts love Woodside and these ASX blue chip shares

Analysts think these blue chips could be quality options in June.

Read more »

Blue Chip Shares

Bell Potter says these ASX 200 shares are strong buys with 20%+ upside

The broker thinks investors should be snapping up these top stocks this month.

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Blue Chip Shares

3 of the best ASX blue chip shares to buy in June

Brokers think these blue chips could be great additions to a portfolio this month.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Blue Chip Shares

Buy these ASX 200 blue-chip stocks for 20% returns

Analysts think big returns could be on offer from these shares.

Read more »

Person holding blue chips.
Opinions

3 ASX 200 blue-chip shares to buy now

I really like these three blue-chip stocks.

Read more »

A businessman lights up the fifth star in a lineup, indicating positive share price for a top performer
Blue Chip Shares

2 of the best ASX 200 blue chip shares that money can buy

Morgans has these blue chips on its best ideas list.

Read more »